Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.)

Size: px
Start display at page:

Download "Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.)"

Transcription

1 PATIENT INFORMATION Last Name First M.I. CLINICAL LABORATORY Date of Birth Gender Ethnicity/Family History Male Female Unknown Molecular Diagnotics Patient or Sample ID# Institutional Account # (415) Fax (415) SPECIMEN INFORMATION SHIP TO: UCSF Clinical Laboratories Collection Date Type of Specimen Attn: Molecular Diagnostics Lab Serum Urine Product of Conception 185 Berry Street, Suite 100 Plasma CSF Tissue Origin: San Francisco, CA Collection Time Whole Blood CVS Other (specify): PLEASE SHIP MONDAY-THURSDAY ONLY Bone Marrow Amniotic Fluid CLIENT / BILLING INFORMATION (Institutional Billing only. We DO NOT bill patients directly.) Weeks Gestation: Institution Name Ordering Physician/Contact Person Telephone Fax # for Reports Department or Division Genetic Counselor Telephone Fax Address Billing Contact Telephone Fax City, State, Zip Billing Address (if different) City, State, Zip For Genetic Testing Only. As the ordering physician/provider, I certify that the patient has been appropriately informed of the test benefits and limitations. Adequate genetic counseling has been offered and written informed consent was obtained. Indication For Testing / Comments / Special Request: Physician/Provider Signature: Date: ICD9 Codes: INHERITED DISORDERS Tel: NEOPLASTIC DISORDERS Tel: MCC Maternal Cell Contamination (maternal and fetal samples) LAV 1P19Q 1p and 19q Deletion by FISH Tissue In addition to EDTA whole blood, most genetic tests listed here can also KDSQ ABL Kinase Domain Mutations LAV/BM be performed on amniotic fluid, CVS samples or cultured cells. For prenatal AML PANEL samples, we recommend also submitting a sample of EDTA whole blood FLT3 FLT3 Mutations, Qualitative PCR LAV/BM from the mother and ordering Maternal Cell Contamination (MCC). NPM1 NPM1 Mutation Detection LAV/BM ACGHC Array CGH, Constitutional LAV CEBPA CEBP Alpha Mutation Sequencing LAV/BM PCGH Array CGH, Family F/U LAV HACGH Hold Array CGH LAV BCRABL BCR/ABL Quantitative by PCR LAV/BM ALSC9 C9orf72 Repeat Expansion LAV BRAF BRAF V600E Mutation testing by RT-PCR Tissue POLT Cystic Fibrosis CBAVD Poly T Mutation LAV EGFR EGFR Amplification by FISH Tissue MCFM Cystic Fibrosis, PCR for Common Mutations LAV ERBB2 ERBB2 FISH (Breast Cancer, Her2/NEU) Tissue FRX Fragile X LAV EWSR1 EWSR1 Gene Rearrangement by FISH Tissue HHEM Hemochromatosis, Hereditary LAV ISO17Q Isochromosome 17q FISH Tissue INVN Hemophilia A Inversion LAV JAK2 Janus kinase 2 Mutation, Qualitative PCR LAV/BM HUNT Huntington's Disease Triplet Repeat LAV JMML JMML Associated Exon Panel (CBL, KRAS, NRAS, PTPN11) LAV/BM PWA Prader-Willi/Angelman Syndromes LAV FJMML JMML Associated Exon Panel, Family F/U LAV SMAPCR Spinal Muscular Atrophy LAV KRAS KRAS Sequencing Tissue THALASSEMIA & HEMOGLOBINOPATHY TESTING MSI Microsatellite Instability by PCR Tissue HbA % MCV fl Date of last transfusion: MGMT MGMT Promotor Methylation Assay Tissue HbF % RBC x10(9)/l MYC MYC FISH (C-MYC FISH) Tissue HbA2 % Fe g/dl Ethnicity: MYCN MYCN FISH (N-MYC FISH) Tissue Other Hb % Ferritin g/dl PMLR PML-RARA PCR, Qualitative LAV/BM HBEP Hemoglobinopathy w/evaluation by HPLC LAV PMLQNT PML-RARA PCR, Quantitative LAV/BM ATHL Alpha Thalassemia Mutations LAV PTEN PTEN Deletion by FISH Tissue HBCS Alpha Thalassemia Point Mutations LAV SS18 SS18 Gene Rearrangement by FISH Tissue BTHL Beta Thalassemia Mutations (incl. HbS, HbC, HbE) LAV UROV UroVysion (TM) FISH (Bladder Cancer) Urine BDEL Beta Globin Gene Deletions by PCR LAV BGSQ Beta-globin DNA Sequencing LAV PHARMACOGENOMICS TESTS Tel: C19 CYP2C19 Genotype LAV THROMBOSIS RISK IL28B IL28B Genotype LAV FVR Factor V (F5) Leiden Mutation LAV UGT1A1 UDP Glucosuronosyltransferase 1A1 LAV MTR Methylenetetrahydrofolate Reductase (MTHFR) mutation LAV WARF Warfarin Metabolism LAV PTTR Prothrombin (20210) mutation LAV OUTREACH SERVICES REQUISITION

2 CLINICAL LABORATORY - Outreach Testing Services Phone (415) Fax (415) Billing Questions: (415) UCSF Use Only Acct #: INSTITUTIONAL ACCOUNT FORM BILLING POLICY: UCSF Clinical Laboratories is unable to bill patients directly or accept any personal insurance plans from outpatients that are not seen at the UCSF Medical Center. An institution account must be established by referring institution prior to sending sample. To establish an account, please complete the required information below and fax to our office at An account # wil be assinged and an itemized invoice will be sent to the referring institution when the test has been completed. INSTITUTION INFORMATION INSTITUTION NAME ORDERING PHYSICIAN NAME DEPARTMENT/DIVISION ADDRESS PHONE (for specimen questions) CITY/STATE/ZIP FAX (For faxing Lab Results) BILLING CONTACT/ADDRESS NAME ADDRESS PHONE ADDRESS FAX CITY/STATE/ZIP GUARANTOR/AUTHORIZED SIGNATURE SIGNATURE PRINT NAME DATE For INTERNATIONAL Samples Only For INTERNATIONAL SAMPLES (outside US), prepayment is required by our Laboratory. Please contact our Laborartory to make arrangements. PLEASE FAX COMPLETED FORM TO (415) , Attn: Kelly Yang THANK YOU

3

4

5

6

7

8

Out-Patient Billing CPT Codes

Out-Patient Billing CPT Codes Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB

More information

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012.

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012. January 1, 2012 Re: 2012 AMA CPT Code Changes Dear Valued Client: The American Medical Association (AMA) has made Current Procedural Terminology (CPT) code changes to the 2012 edition of the CPT coding

More information

ACMG/CAP Cytogenetics CY

ACMG/CAP Cytogenetics CY www.cap.org Cytogenetics Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services ACMG/CAP Cytogenetics CY Analyte CY Challenges per Shipment

More information

August 17, Dear Valued Client:

August 17, Dear Valued Client: August 7, 08 Re: CMS Announces 6-Month Period of Enforcement Discretion for Laboratory Date of Service Exception Policy Under the Medicare Clinical Laboratory Fee Schedule (the 4 Day Rule ) Dear Valued

More information

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays TECHNICAL NOTICE The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays December 2012 The notation (MAAA) indicates "Multianalyte Assay with

More information

Russell-Silver syndrome (RSS)

Russell-Silver syndrome (RSS) GENETIC DIAGNOSTIC LABORATORY Russell-Silver syndrome (RSS) Background: Russell-Silver syndrome (RSS, OMIM 103280, 180860) is a growth disorder characterized by intrauterine and postnatal growth retardation,

More information

LIST OF INVESTIGATIONS

LIST OF INVESTIGATIONS Karyotyping: K001 K002 LIST OF INVESTIGATIONS SAMPLE CONTAINER TYPE cells For Karyotyping [Single] cells For Karyotyping [Couple] Vacutainer Vacutainer 7-8 7-8 K003 Fetal Blood Sample For Karyotyping Vacutainer

More information

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days TEST MENU CANCER/LEUKEMIA CHROMOSOME ANALYSIS Chromosome Analysis Bone Marrow 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis Bone Marrow Core 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome

More information

Molecular and Cellular Biology Unit School of Life Sciences Manipal University Manipal

Molecular and Cellular Biology Unit School of Life Sciences Manipal University Manipal D i a g n o s t i c Te s t s Molecular and Cellular Biology Unit Manipal University Manipal 576 104 Contact Tel: 0820 2922058; 0820 2923501 Email: dbt@manipal.edu Working Hours Monday to Saturday (9:00

More information

Select analysis on the next pages. Sample request and sending address see last page. Institut für Pathologie und Molekularpathologie

Select analysis on the next pages. Sample request and sending address see last page. Institut für Pathologie und Molekularpathologie Diagnostic Tumor Genome Analysis Schmelzbergstrasse 12 8091 Zürich Tel.: (+41) 044 255 3929 Fax.: (+41) 044 255 4416 Client (address, telephone number): ngs.pathologie@usz.ch www.pathologie.usz.ch Sample-Nr:

More information

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy. Molecular Oncology & Pathology Hereditary Cancer Somatic Cancer Liquid Biopsy Next-Gen Sequencing qpcr Sanger Sequencing Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test TAT ** Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative)

More information

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other:

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other: REQUEST FOR BECKWITH-WIEDEMANN SYNDROME (BWS) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information

Oxford BRC Haemato-Molecular Diagnostic Service

Oxford BRC Haemato-Molecular Diagnostic Service Short User Guide Oxford BRC Haemato-Molecular Diagnostic Service The Oxford University Hospitals NHS trust s department of Haematology provides a comprehensive molecular diagnostic service for a range

More information

EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR)

EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR) THE UNIVERSITY OF TEXAS *Required Fields PHYSICIAN! FACILITY/ CLIENT INFORMATION MDAndersonefief &ter MaltgararEettcy 'REQUESTING PHYSICIAN Division of Pathology! Laboratory Medicine Services Test Requisition

More information

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5 Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition

More information

National Haemoglobinopathy Reference Laboratory. Information for Users

National Haemoglobinopathy Reference Laboratory. Information for Users National Haemoglobinopathy Reference Laboratory Information for Users Summary The NHRL offers a service for the identification of haemoglobinopathy genotypes by the molecular analysis of DNA and haematological

More information

Should Universal Carrier Screening be Universal?

Should Universal Carrier Screening be Universal? Should Universal Carrier Screening be Universal? Disclosures Research funding from Natera Mary E Norton MD University of California, San Francisco Antepartum and Intrapartum Management June 15, 2017 Burden

More information

molecular oncology services

molecular oncology services Molecular Oncology molecular oncology services ATIENTS.ANSWERS.RESULTS. www.aruplab.com/oncology MARCH 2018 Information in this brochure is current as of March 2018. All content is subject to change. lease

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information

Integrating the Latest in Genomic Science into Modern Medical Practice

Integrating the Latest in Genomic Science into Modern Medical Practice Integrating the Latest in Genomic Science into Modern Medical Practice Mayo Clinic Center for Individualized Medicine Datapalooza DC, 2017 4/21/2017 1 My Genome is an iron overloaded, lipid accumulating,

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for

More information

6.1 Extended family screening

6.1 Extended family screening CHAPTER 6 CONCLUSION Cost benefit analysis of thalassemia screening programs have shown that the single years treatment for a β-thalassemia major patient was much higher than a total cost per case prevented.

More information

MOLECULAR SERVICES. mlabs.umich.edu

MOLECULAR SERVICES. mlabs.umich.edu MOLECULAR SERVICES mlabs.umich.edu 800.862.7284 PICTURED ON LEFT IS MARWAN TAYEH, PH.D, CLINICAL ASSISTANT PROFESSOR, PEDIATRICS - GENETICS, ON RIGHT IS TODD ACKLEY, LABORATORY MANAGER MLabs is a full-service

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles Multimethod Analysis of 25+ Hematologic Diseases and Solid Tumors Anatomic Pathology FISH Molecular The next generation of diagnostic, prognostic, and therapeutic assessment NeoTYPE

More information

helpful guide Carrier Testing for Common Genetic Diseases Hemoglobinopathies Cystic Fibrosis Spinal Muscular Atrophy Fragile X

helpful guide Carrier Testing for Common Genetic Diseases Hemoglobinopathies Cystic Fibrosis Spinal Muscular Atrophy Fragile X A helpful guide to Carrier Testing for Common Genetic Diseases Hemoglobinopathies Cystic Fibrosis Spinal Muscular Atrophy Fragile X Joseph Adashek, M.D., FACOG Paul T. Wilkes, M.D., FACOG Van R. Bohman,

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1

More information

The Thalassemias in Clinical Practice. Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland

The Thalassemias in Clinical Practice. Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland The Thalassemias in Clinical Practice Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland Outline Thalassemia: definitions and pathophysiology Epidemiology

More information

YES. If yes, indicate what types of tumors/polyps and age of onset:

YES. If yes, indicate what types of tumors/polyps and age of onset: REQUEST FOR FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION

More information

IMMEDIATE HOT LINE: Effective January 6, 2014

IMMEDIATE HOT LINE: Effective January 6, 2014 MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only

More information

Moms Help Organization Helping Moms to be the best Moms they can be! West Sample Road, #24 Coral Springs, FL

Moms Help Organization Helping Moms to be the best Moms they can be! West Sample Road, #24 Coral Springs, FL Moms Help Organization Helping Moms to be the best Moms they can be! 11471 West Sample Road, #24 Coral Springs, FL 33065 www.momshelp.org Application for Assistance Welcome to the Moms Help Organization.

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK SW Thames Regional Genetics Laboratory, Jenner Wing, SGUL Cranmer Terrace London SW17 0RE Contact: Mr John Short Tel: +44 (0) 208 725 5332 Fax: +44 (0) 208 725 3440 E-Mail: swtrgl@stgeorges.nhs.uk Website:

More information

Alpha-1 Antitrypsin (AAT) Mutation Analysis

Alpha-1 Antitrypsin (AAT) Mutation Analysis Alpha-1 Antitrypsin (AAT) Mutation Analysis Order Name: ALPH 1 MUT Test Number: 3805175 Alpha-1 Antitrypsin (AAT) Mutation Analysis PCR Type Container Transport Preferred 5 ml (2) Whole Blood EDTA (Lavender

More information

Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD

Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD Introduction is the iron-containing oxygen transport metalloprotein in the red blood cells Hemoglobin in the blood carries oxygen from the respiratory organs

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University Hospitals NHS Foundation Trust, Level 1, The Women s Centre John Radcliffe Hospital University Hospitals NHS Foundation Trust OX3

More information

CYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING

CYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING INTRODUCTION The Cytogenetics Laboratory offers a comprehensive array of chromosome investigations for cancers, constitutional abnormalities, and prenatal and postnatal diagnosis. Analyses are performed

More information

Transform genomic data into real-life results

Transform genomic data into real-life results CLINICAL SUMMARY Transform genomic data into real-life results Biomarker testing and targeted therapies can drive improved outcomes in clinical practice New FDA-Approved Broad Companion Diagnostic for

More information

Haemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference October 2017

Haemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference October 2017 Haemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference 11 13 October 2017 Chris Lambert Haematology Service Delivery Manager Viapath Laboratories Kings College Hospital HUMAN

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles 30+ Multimethod Assays for Hematologic Diseases and Solid Tumors Molecular FISH Anatomic Pathology The next generation of diagnostic, prognostic, and therapeutic assessment What

More information

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition:

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition: Patient Information Specimen Information Client Information MAIL000 Requisition: 0014895 DIRECT TO PATIENT- WEST HILLS Lab Ref #: PRO76199 8401 FALLBROOK AVE WEST HILLS, CA 91304-3226 Phone: 530.347.6380

More information

The Center for PERSONALIZED DIAGNOSTICS

The Center for PERSONALIZED DIAGNOSTICS The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)

More information

TEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647

TEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647 Ordering Practice Jane Smith John Smith Practice Code: 675 Miller MD 374 Broadway New York, NY 10000 Physician: Dr. Frank Miller Report Generated: 2016-02-03 DOB: 1973-02-19 Gender: Female Ethnicity: European

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Building 9 Contact: Dr Catherine Sturgeon BioQuarter Tel: +44 (0)131-2426885 Little France Road Fax: +44 (0)131-242-6882 E-Mail: c.sturgeon@ed.ac.uk Websites: http://edqas.org EH16 4UX Proficiency Testing

More information

Counsyl Foresight Carrier Screen. Utmost confidence in every result

Counsyl Foresight Carrier Screen. Utmost confidence in every result Counsyl Foresight Carrier Screen Utmost confidence in every result EXTENDING THE BENEFITS OF CARRIER SCREENING Elevate quality of care with expanded carrier screening (ECS) Carrier screening is used to

More information

Z Code Listing. Performing Site Test Code Test Description Z Code CPT Codes* IU 75950R 1p 19q FISH ZB1K BCL6 Break apart

Z Code Listing. Performing Site Test Code Test Description Z Code CPT Codes* IU 75950R 1p 19q FISH ZB1K BCL6 Break apart Z Code Listing Performing Site Test Code Test Description Z Code CPT Codes* IU 75950R 1p 19q FISH ZB1K4 BCL6 Break apart IU 75989 FISH ZB1K7 c-myc Break apart IU 75948 FISH ZB1KQ IU 75993 Her2 neu FISH

More information

Z Code Listing. Performing Site Test Code Test Description Z Code CPT Codes* IU 75950R 1p 19q FISH ZB1K BCL6 Break apart

Z Code Listing. Performing Site Test Code Test Description Z Code CPT Codes* IU 75950R 1p 19q FISH ZB1K BCL6 Break apart Z Code Listing Performing Site Test Code Test Description Z Code CPT Codes* IU 75950R 1p 19q FISH ZB1K4 BCL6 Break apart IU 75989 FISH ZB1K7 c-myc Break apart IU 75948 FISH ZB1KQ IU 75993 Her2 neu FISH

More information

Blastic Plasmacytoid Dendritic Cell Neoplasm with DNMT3A and TET2 mutations (SH )

Blastic Plasmacytoid Dendritic Cell Neoplasm with DNMT3A and TET2 mutations (SH ) Blastic Plasmacytoid Dendritic Cell Neoplasm with DNMT3A and TET2 mutations (SH2017-0314) Habibe Kurt, Joseph D. Khoury, Carlos E. Bueso-Ramos, Jeffrey L. Jorgensen, Guilin Tang, L. Jeffrey Medeiros, and

More information

Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making

Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making November 20, 2014 Capturing Value in Next Generation Sequencing Symposium Douglas Johnson MD, MSCI Vanderbilt-Ingram

More information

Genetic Testing for Pharmacogenetics

Genetic Testing for Pharmacogenetics Genetic Testing for Pharmacogenetics MP9479 Covered Service: Yes when meets criteria below Prior Authorization Required: Yes-as shown below (1.0 and 3.0) Additional Information: None Prevea360 Health Plan

More information

Genomic Medicine: What every pathologist needs to know

Genomic Medicine: What every pathologist needs to know Genomic Medicine: What every pathologist needs to know Stephen P. Ethier, Ph.D. Professor, Department of Pathology and Laboratory Medicine, MUSC Director, MUSC Center for Genomic Medicine Genomics and

More information

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Talking Genomes with Your Patients Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Objectives Review the importance of physician familiarity with genomic testing

More information

PATIENT EDUCATION. carrier screening INFORMATION

PATIENT EDUCATION. carrier screening INFORMATION PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your

More information

Developments in Laboratory Genetics

Developments in Laboratory Genetics Developments in Laboratory Genetics Rachel Butler rachel.butler@wales.nhs.uk The Impact of Genomics on Public Health Where are we now? Single gene disorders Core disorders Newborn screening (CF, MCAD)

More information

Comprehensive Hemoglobin Analysis HBA1/2 (

Comprehensive Hemoglobin Analysis HBA1/2 ( Comprehensive Hemoglobin Analysis HBA1/2 ( α-globin) and HBB (β-globin) mutation and deletion/duplication analysis and HBD (δ-globin) and HBG1/2 (γ-globin) mutation analysis Description: Hemoglobin (Hb)

More information

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains Thalassaemias Thalassemia Thalassemia is an inherited autosomal recessive blood disease. Associated with absence or reduction in a or b globin chains. Reduced synthesis of one of the globin chains can

More information

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Molecular Diagnostics Overview JAN A. NOWAK, PHD, MD PATHOLOGY AND LABORATORY MEDICINE MOLECULAR DIAGNOSTICS LABORATORY FEBRUARY 15, 2018

Molecular Diagnostics Overview JAN A. NOWAK, PHD, MD PATHOLOGY AND LABORATORY MEDICINE MOLECULAR DIAGNOSTICS LABORATORY FEBRUARY 15, 2018 Molecular Diagnostics Overview JAN A. NOWAK, PHD, MD PATHOLOGY AND LABORATORY MEDICINE MOLECULAR DIAGNOSTICS LABORATORY FEBRUARY 15, 2018 Some Key Points Molecular Testing has applications in every section

More information

Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation

Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation Chris Miller, MS, LCGC ARUP Laboratories Learning Objectives Understand the relevance of clinical information for

More information

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters XXXth International Symposium on Technical Innovations in Laboratory Hematology Honolulu, Hawaii

More information

Medical Policy Update

Medical Policy Update Medical Policy Update Summer 2017 Highlights of recent medical policy revisions as well as any new medical policies approved by Prevea360 Health Plan s Medical Policy Committee are shown below. The Medical

More information

Movement Disorders Requisition Form

Movement Disorders Requisition Form Movement Disorders Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax:

More information

Testing for Fabry Disease. What You Need to Know

Testing for Fabry Disease. What You Need to Know Testing for Fabry Disease What You Need to Know Identification of One Family Member Can Enable Earlier Screening for Others A woman with Fabry disease may have inherited it from either her mother or her

More information

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014 Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October

More information

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition: TSENG, JUSTINA J DOB: 10/26/1955 AGE: 59

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition: TSENG, JUSTINA J DOB: 10/26/1955 AGE: 59 Report Status: Final Patient Information Specimen Information Client Information Specimen: EN255254W Client #: 44123510 MAIL001 Requisition: 0014895 Lab Ref #: PRO76199 GREENVILLE RANCHERIA 1425 MONTGOMERY

More information

Cardiovascular Molecular Cytogenetics Methylenetetrahydrofolate Oligodendrogliomas Reductase (MTHFR) Mutation SS18 (C677T & A1298C) QF-PCR Sample:

Cardiovascular Molecular Cytogenetics Methylenetetrahydrofolate Oligodendrogliomas Reductase (MTHFR) Mutation SS18 (C677T & A1298C) QF-PCR Sample: Genetics Testing Dorevitch Pathology offers a comprehensive range of molecular and cytogenetic tests covering a wide spectrum of clinical indications to help in the diagnosis, management and treatment

More information

Diagnostic test Suggested website label Description Hospitals available

Diagnostic test Suggested website label Description Hospitals available Diagnostic test Suggested website label Description Hospitals available Abbott Molecular Inc, PATHVYSION HER-2 DNA Probe Kit (FISH) PathVysion kit A diagnostic tool used to determine whether a particular

More information

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome 3.3 X 10 9 DNA basepairs Estimated genetic constitution 30,000

More information

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome! Estimated genetic constitution! Size of average chromosome

More information

Test Requisition Form

Test Requisition Form Accession: For MGL Laboratory Use only Test Requisition Form This form must accompany all specimens received. Billing instructions are available on page 4 All specimens received must include two patient

More information

ON O C N O C H O E H M E A M T A O T L O O L G O Y

ON O C N O C H O E H M E A M T A O T L O O L G O Y REAL TIME PCR KITS von AB Analitica www.bioproducts.at ONKOHÄMATOLOGIE INFEKTIOLOGIE HUMANGENTIK CE IVD gleiches PCR Protokoll REALQUALITY CATALOGUE REALQUALITY REAL TIME PCR KITS Characteristics: CE IVD

More information

Your single-source laboratory solution. FISH Probe Library

Your single-source laboratory solution. FISH Probe Library Your single-source laboratory solution. FISH Probe Library Alphabetical List by Probe with Clinical Indication Probe Clinical Indication 1p36 (TP73)/19q13 (GLTSCR) 1q21 (CKS1B) 5q (CSF1R/RPS14) 7q (MDFIC)

More information

Yes if indicated below. (4.0 TMPT does not require prior authorization)

Yes if indicated below. (4.0 TMPT does not require prior authorization) Genetic Testing for Pharmacogenetics MP9479 Covered Service: Prior Authorization Required: Additional Information: Medicare Policy: BadgerCare Plus Policy: Yes when meets criteria below Yes if indicated

More information

Thalassemia Maria Luz Uy del Rosario, M.D.

Thalassemia Maria Luz Uy del Rosario, M.D. Thalassemia Maria Luz Uy del Rosario, M.D. Philippine Society of Hematology and Blood Transfusion Philippine Society of Pediatric Oncology What is Thalassemia Hereditary Hemoglobin disorder Hemolytic anemia

More information

Illumina Clinical Services Laboratory

Illumina Clinical Services Laboratory Illumina Clinical Services Laboratory Illumina, Inc. 5200 Illumina Way San Diego, CA 92122, USA Phone: 858.736.8080 Fax: 858.255.5285 everygenome@illumina.com CLIA Certificate No.: 05D1092911 Illumina

More information

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First #: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST

More information

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community.

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community. IntelliGENSM Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community. NGS TRANSFORMS GENOMIC TESTING Background Cancers may emerge as a result of somatically

More information

Thalassemias. Emanuela Veras, M.D. 01/08/2006

Thalassemias. Emanuela Veras, M.D. 01/08/2006 Thalassemias Emanuela Veras, M.D. 01/08/2006 Structure and Function of normal Hemoglobin molecules: 2/3 1/3 β: increases from 6 th week of fetal life to 12 months of age At birth: HbF: 75-90% HbA: 10-25%

More information

July Monthly Update, Quest Diagnostics Nichols Institute, Valencia

July Monthly Update, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Name Effective Date Page #

More information

Thalassemias:general aspects and molecular pathology

Thalassemias:general aspects and molecular pathology Thalassemias:general aspects and molecular pathology Prof. Renzo Galanello Pediatric Clinic 2 University of Cagliari Ospedale Regionale Microcitemie-ASL8 HEMOGLOBINOPATHIES CLASSIFICATION Structurally

More information

Original Policy Date

Original Policy Date MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer

More information

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately

More information

Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation. Chris Miller, MS, LCGC ARUP Laboratories

Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation. Chris Miller, MS, LCGC ARUP Laboratories Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation Chris Miller, MS, LCGC ARUP Laboratories Learning Objectives Explain the relevance of clinical information for genetic

More information

Report of Beta Thalassemia in Newar Ethnicity

Report of Beta Thalassemia in Newar Ethnicity Report of Beta Thalassemia in Newar Ethnicity Rajendra Dev Bhatt 1*, Surendra Koju 2, Prabodh Risal 1 Affiliations: 1 Department of Clinical Biochemistry, Dhulikhel Hospital, Kathmandu University Hospital

More information

Sequencing in Newborn Screening Introduction and Background

Sequencing in Newborn Screening Introduction and Background Sequencing in Newborn Screening Introduction and Background Suzanne Cordovado, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Centers for Disease Control and Prevention

More information

Anatomic Molecular Pathology: An Emerging Field

Anatomic Molecular Pathology: An Emerging Field Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty

More information

Expanded Carrier Screening: What s Best?

Expanded Carrier Screening: What s Best? Expanded Carrier Screening: What s Best? James D Goldberg, MD September 17, 2017 Disclosures James D. Goldberg, M.D. Chief Medical Officer, Counsyl 3 Learning Objectives Guidelines Data Design Practice

More information

FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:

FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship: REQUEST FOR GERMLINE BAP1TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST NAME MI LAST

More information

SNP Microarray. Prenatal

SNP Microarray. Prenatal SNP Microarray Prenatal SNP Microarray Reveal SNP Microarray is a test that analyzes chromosomes for changes that can explain certain kinds of birth defects. This brochure is designed to answer some of

More information

CPT Codes for Pharmacogenomic Tests

CPT Codes for Pharmacogenomic Tests CPT s for Pharmacogenomic Tests The table below lists CPT codes and lab fee information for pharmacogenomic tests as established by the Centers for Medicare and Medicaid Services. It was compiled by the

More information

Genetic testing for hereditary cancer. An overview for healthcare providers

Genetic testing for hereditary cancer. An overview for healthcare providers Genetic testing for hereditary cancer An overview for healthcare providers Specimen requirements Whole blood Two 4.5 ml EDTA tubes (lavender top) Please wait at least 2 weeks after a packed cell/platelet

More information

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately

More information

Intellectual Disability Exome Panel Requisition Form

Intellectual Disability Exome Panel Requisition Form Intellectual Disability Exome Panel Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local:

More information

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS APPLICATION NOTE Fluxion Biosciences and Swift Biosciences OVERVIEW This application note describes a robust method for detecting somatic mutations from liquid biopsy samples by combining circulating tumor

More information

The Next Generation of Hereditary Cancer Testing

The Next Generation of Hereditary Cancer Testing The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,

More information

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW.

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. EVOLVE CARRIER GENETIC SCREENS Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. PROTECT THE HEALTH OF YOUR FUTURE CHILDREN BY KNOWING YOUR GENETIC RISKS, TODAY! Carrier

More information

School of Pathology and Laboratory Medicine: Current and New Research Interests

School of Pathology and Laboratory Medicine: Current and New Research Interests School of Pathology and Laboratory Medicine: Current and New Research Interests W/Professor Wendy Erber Current Research Interests Viral immunology and immunogenetics Bone pathology and cell signalling

More information